IMMODULON THERAPEUTICS LTD.
Immodulon is a privately-owned immuno-oncology company primarily focused on the development of novel, safe, effective and potentially valuable treatments for cancer. Their IMM-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. They are currently developing treatments for advanced melanoma, a skin cancer, and for advanced pancreatic cancer.
IMMODULON THERAPEUTICS LTD.
Social Links:
Industry:
Biotechnology Therapeutics
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.immodulon.com
Total Employee:
11+
Status:
Active
Contact:
+44 (0) 20 3137 6346
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics
Similar Organizations
GlyTherix Ltd.
GlyTherix Ltd. is an Australian immuno-oncology company
ImmunOs Therapeutics
ImmunOs Therapeutics is a clinical-stage biotechnology company.
Current Employees Featured
Cellia Habita
Cellia Habita CMO @ Immodulon Therapeutics Ltd. CMO 2020-04-01
Cellia Habita
Cellia Habita CEO @ Immodulon Therapeutics Ltd. CEO 2021-09-01
Founder
John L Stanford
Official Site Inspections
http://www.immodulon.com
- Host name: 128427.cloudwaysapps.com
- IP address: 139.59.163.126
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
Loading ...